
Molson Coors Beverage Company (TAP)
NYSEConsumer StaplesBeverages - BrewersSnapshot 2026-07-07
Reading TAP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TAP free→
NYSEConsumer StaplesBeverages - BrewersSnapshot 2026-07-07
Reading TAP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TAP free→QuarterlyIQ Insights · TAP
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $39.26. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $39 TAP trades at 6.9× p/e, below its 19× p/e peer median. Our $72 fair value sits well above the price. We hold it with low confidence: our number sits well above the analyst range and the peer anchor overstates how cheap it looks. Analysts target $41–$46. Note: our $72 fair value sits above the entire analyst range ($41–$46). Not investment advice.
$41.00 – $46.00 (median $42.50) · 4 analysts · as of 2026-05-04
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $4.39/sh owner earnings.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $42.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $102.43 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $115.17 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $30.12 | — | — | TTM | high |
| graham number | 12M | $82.42 | — | — | TTM | high |
| Peer P/FCF | 12M | $119.91 | 20.3 | 5.89 | TTM | high |
| Peer P/E | 12M | $110.31 | 19.3 | 5.73 | TTM | high |
| Peer P/S | 12M | $112.07 | 1.7 | 65.89 | TTM | high |
| residual income | 12M | $56.68 | — | — | TTM | high |
| Own P/E history | 12M | $50.25 | 8.8 | 5.73 | TTM | high |
| triangulated | 12M | $114.27 | 19.3 | 5.94 | Triangulated | high |
| Peer P/FCF | 3Y | $136.38 | 20.3 | 6.70 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $83.44 | 19.3 | 4.33 | Analyst | medium |
| Peer P/S | 3Y | $112.07 | 1.7 | 65.89 | guidance | medium |
| Own P/E history | 3Y | $38.01 | 8.8 | 4.33 | Analyst | medium |
| Peer P/FCF | 5Y | $148.60 | 20.3 | 7.31 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $69.27 | 19.3 | 3.60 | Analyst | medium |
| Peer P/S | 5Y | $112.07 | 1.7 | 65.89 | guidance | medium |
| Own P/E history | 5Y | $31.55 | 8.8 | 3.60 | Analyst | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.